Global Cancer Hormone Therapy Drugs Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Table of Contents

1 Cancer Hormone Therapy Drugs Market Overview

• 1.1 Product Overview and Scope of Cancer Hormone Therapy Drugs
• 1.2 Classification of Cancer Hormone Therapy Drugs by Types
  • 1.2.1 Global Cancer Hormone Therapy Drugs Revenue Comparison by Types (2019-2024)
  • 1.2.2 Global Cancer Hormone Therapy Drugs Revenue Market Share by Types in 2018
  • 1.2.3 Tamoxifen
  • 1.2.4 Aromatase Inhibitors
  • 1.2.5 Antiandrogens
  • 1.2.6 Androgen Synthesis Inhibitors
  • 1.2.7 Other
• 1.3 Global Cancer Hormone Therapy Drugs Market by Application
  • 1.3.1 Global Cancer Hormone Therapy Drugs Market Size and Market Share Comparison by Applications (2014-2024)
  • 1.3.2 Breast Cancer
  • 1.3.3 Prostate Cancer
• 1.4 Global Cancer Hormone Therapy Drugs Market by Regions
  • 1.4.1 Global Cancer Hormone Therapy Drugs Market Size (Million USD) Comparison by Regions (2014-2024)
  • 1.4.1 North America (USA, Canada and Mexico) Cancer Hormone Therapy Drugs Status and Prospect (2014-2024)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Cancer Hormone Therapy Drugs Status and Prospect (2014-2024)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Cancer Hormone Therapy Drugs Status and Prospect (2014-2024)
  • 1.4.4 South America (Brazil, Argentina, Colombia) Cancer Hormone Therapy Drugs Status and Prospect (2014-2024)
  • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Cancer Hormone Therapy Drugs Status and Prospect (2014-2024)
• 1.5 Global Market Size of Cancer Hormone Therapy Drugs (2014-2024)

2 Manufacturers Profiles

• 2.1 Roche
  • 2.1.1 Business Overview
  • 2.1.2 Cancer Hormone Therapy Drugs Type and Applications
    • 2.1.2.1 Product A
    • 2.1.2.2 Product B
  • 2.1.3 Roche Cancer Hormone Therapy Drugs Revenue, Gross Margin and Market Share (2017-2018)
• 2.2 Amgen
  • 2.2.1 Business Overview
  • 2.2.2 Cancer Hormone Therapy Drugs Type and Applications
    • 2.2.2.1 Product A
    • 2.2.2.2 Product B
  • 2.2.3 Amgen Cancer Hormone Therapy Drugs Revenue, Gross Margin and Market Share (2017-2018)
• 2.3 Pfizer
  • 2.3.1 Business Overview
  • 2.3.2 Cancer Hormone Therapy Drugs Type and Applications
    • 2.3.2.1 Product A
    • 2.3.2.2 Product B
  • 2.3.3 Pfizer Cancer Hormone Therapy Drugs Revenue, Gross Margin and Market Share (2017-2018)
• 2.4 Teva
  • 2.4.1 Business Overview
  • 2.4.2 Cancer Hormone Therapy Drugs Type and Applications
    • 2.4.2.1 Product A
    • 2.4.2.2 Product B
  • 2.4.3 Teva Cancer Hormone Therapy Drugs Revenue, Gross Margin and Market Share (2017-2018)
• 2.5 Takeda
  • 2.5.1 Business Overview
  • 2.5.2 Cancer Hormone Therapy Drugs Type and Applications
    • 2.5.2.1 Product A
    • 2.5.2.2 Product B
  • 2.5.3 Takeda Cancer Hormone Therapy Drugs Revenue, Gross Margin and Market Share (2017-2018)
• 2.6 Samyang Biopharmaceuticals
  • 2.6.1 Business Overview
  • 2.6.2 Cancer Hormone Therapy Drugs Type and Applications
    • 2.6.2.1 Product A
    • 2.6.2.2 Product B
  • 2.6.3 Samyang Biopharmaceuticals Cancer Hormone Therapy Drugs Revenue, Gross Margin and Market Share (2017-2018)
• 2.7 Tolmar
  • 2.7.1 Business Overview
  • 2.7.2 Cancer Hormone Therapy Drugs Type and Applications
    • 2.7.2.1 Product A
    • 2.7.2.2 Product B
  • 2.7.3 Tolmar Cancer Hormone Therapy Drugs Revenue, Gross Margin and Market Share (2017-2018)
• 2.8 AstraZeneca
  • 2.8.1 Business Overview
  • 2.8.2 Cancer Hormone Therapy Drugs Type and Applications
    • 2.8.2.1 Product A
    • 2.8.2.2 Product B
  • 2.8.3 AstraZeneca Cancer Hormone Therapy Drugs Revenue, Gross Margin and Market Share (2017-2018)
• 2.9 Novartis
  • 2.9.1 Business Overview
  • 2.9.2 Cancer Hormone Therapy Drugs Type and Applications
    • 2.9.2.1 Product A
    • 2.9.2.2 Product B
  • 2.9.3 Novartis Cancer Hormone Therapy Drugs Revenue, Gross Margin and Market Share (2017-2018)
• 2.10 Aspen
  • 2.10.1 Business Overview
  • 2.10.2 Cancer Hormone Therapy Drugs Type and Applications
    • 2.10.2.1 Product A
    • 2.10.2.2 Product B
  • 2.10.3 Aspen Cancer Hormone Therapy Drugs Revenue, Gross Margin and Market Share (2017-2018)

3 Global Cancer Hormone Therapy Drugs Market Competition, by Players

• 3.1 Global Cancer Hormone Therapy Drugs Revenue and Share by Players (2014-2019)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 Cancer Hormone Therapy Drugs Players Market Share
  • 3.2.2 Top 10 Cancer Hormone Therapy Drugs Players Market Share
• 3.3 Market Competition Trend

4 Global Cancer Hormone Therapy Drugs Market Size by Regions

• 4.1 Global Cancer Hormone Therapy Drugs Revenue and Market Share by Regions
• 4.2 North America Cancer Hormone Therapy Drugs Revenue and Growth Rate (2014-2019)
• 4.3 Europe Cancer Hormone Therapy Drugs Revenue and Growth Rate (2014-2019)
• 4.4 Asia-Pacific Cancer Hormone Therapy Drugs Revenue and Growth Rate (2014-2019)
• 4.5 South America Cancer Hormone Therapy Drugs Revenue and Growth Rate (2014-2019)
• 4.6 Middle East and Africa Cancer Hormone Therapy Drugs Revenue and Growth Rate (2014-2019)

5 North America Cancer Hormone Therapy Drugs Revenue by Countries

• 5.1 North America Cancer Hormone Therapy Drugs Revenue by Countries (2014-2019)
• 5.2 USA Cancer Hormone Therapy Drugs Revenue and Growth Rate (2014-2019)
• 5.3 Canada Cancer Hormone Therapy Drugs Revenue and Growth Rate (2014-2019)
• 5.4 Mexico Cancer Hormone Therapy Drugs Revenue and Growth Rate (2014-2019)

6 Europe Cancer Hormone Therapy Drugs Revenue by Countries

• 6.1 Europe Cancer Hormone Therapy Drugs Revenue by Countries (2014-2019)
• 6.2 Germany Cancer Hormone Therapy Drugs Revenue and Growth Rate (2014-2019)
• 6.3 UK Cancer Hormone Therapy Drugs Revenue and Growth Rate (2014-2019)
• 6.4 France Cancer Hormone Therapy Drugs Revenue and Growth Rate (2014-2019)
• 6.5 Russia Cancer Hormone Therapy Drugs Revenue and Growth Rate (2014-2019)
• 6.6 Italy Cancer Hormone Therapy Drugs Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Cancer Hormone Therapy Drugs Revenue by Countries

• 7.1 Asia-Pacific Cancer Hormone Therapy Drugs Revenue by Countries (2014-2019)
• 7.2 China Cancer Hormone Therapy Drugs Revenue and Growth Rate (2014-2019)
• 7.3 Japan Cancer Hormone Therapy Drugs Revenue and Growth Rate (2014-2019)
• 7.4 Korea Cancer Hormone Therapy Drugs Revenue and Growth Rate (2014-2019)
• 7.5 India Cancer Hormone Therapy Drugs Revenue and Growth Rate (2014-2019)
• 7.6 Southeast Asia Cancer Hormone Therapy Drugs Revenue and Growth Rate (2014-2019)

8 South America Cancer Hormone Therapy Drugs Revenue by Countries

• 8.1 South America Cancer Hormone Therapy Drugs Revenue by Countries (2014-2019)
• 8.2 Brazil Cancer Hormone Therapy Drugs Revenue and Growth Rate (2014-2019)
• 8.3 Argentina Cancer Hormone Therapy Drugs Revenue and Growth Rate (2014-2019)
• 8.4 Colombia Cancer Hormone Therapy Drugs Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Cancer Hormone Therapy Drugs by Countries

• 9.1 Middle East and Africa Cancer Hormone Therapy Drugs Revenue by Countries (2014-2019)
• 9.2 Saudi Arabia Cancer Hormone Therapy Drugs Revenue and Growth Rate (2014-2019)
• 9.3 UAE Cancer Hormone Therapy Drugs Revenue and Growth Rate (2014-2019)
• 9.4 Egypt Cancer Hormone Therapy Drugs Revenue and Growth Rate (2014-2019)
• 9.5 Nigeria Cancer Hormone Therapy Drugs Revenue and Growth Rate (2014-2019)
• 9.6 South Africa Cancer Hormone Therapy Drugs Revenue and Growth Rate (2014-2019)

10 Global Cancer Hormone Therapy Drugs Market Segment by Type

• 10.1 Global Cancer Hormone Therapy Drugs Revenue and Market Share by Type (2014-2019)
• 10.2 Global Cancer Hormone Therapy Drugs Market Forecast by Type (2019-2024)
• 10.3 Tamoxifen Revenue Growth Rate (2014-2024)
• 10.4 Aromatase Inhibitors Revenue Growth Rate (2014-2024)
• 10.5 Antiandrogens Revenue Growth Rate (2014-2024)
• 10.6 Androgen Synthesis Inhibitors Revenue Growth Rate (2014-2024)
• 10.7 Other Revenue Growth Rate (2014-2024)

11 Global Cancer Hormone Therapy Drugs Market Segment by Application

• 11.1 Global Cancer Hormone Therapy Drugs Revenue Market Share by Application (2014-2019)
• 11.2 Cancer Hormone Therapy Drugs Market Forecast by Application (2019-2024)
• 11.3 Breast Cancer Revenue Growth (2014-2019)
• 11.4 Prostate Cancer Revenue Growth (2014-2019)

12 Global Cancer Hormone Therapy Drugs Market Size Forecast (2019-2024)

• 12.1 Global Cancer Hormone Therapy Drugs Market Size Forecast (2019-2024)
• 12.2 Global Cancer Hormone Therapy Drugs Market Forecast by Regions (2019-2024)
• 12.3 North America Cancer Hormone Therapy Drugs Revenue Market Forecast (2019-2024)
• 12.4 Europe Cancer Hormone Therapy Drugs Revenue Market Forecast (2019-2024)
• 12.5 Asia-Pacific Cancer Hormone Therapy Drugs Revenue Market Forecast (2019-2024)
• 12.6 South America Cancer Hormone Therapy Drugs Revenue Market Forecast (2019-2024)
• 12.7 Middle East and Africa Cancer Hormone Therapy Drugs Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology